Come up with a name for your new list and we'll add to it:
Adaptive Biotechnologies raised a round of funding on September 13, 2013. Investors include
National Institutes of Health.
Adaptive Biotechnologies, formerly Adaptive TCR, is a pioneer in immunosequencing diagnostics, with a focus in oncology. The Company leverages advances in next generation sequencing ("NGS") to profile…